COVID-19 INFORMATION AND RESOURCES
FOUR WAYS TO REMAIN VIGILANT ABOUT COVID-19
Perspectives on COVID-19 from Mace Rothenberg, M.D.
PARTNERING WITH DIRECT RELIEF TO PROVIDE COVID-19 SUPPLIES TO HOSPITALS
Age: Addressing a Blind Spot in Cancer Care
Supply of 120 million doses to be provided in the first half of 2021, subject to regulatory approval Agreement is part of Pfizer’s and BioNTech’s global commitment to help address the pandemic Pfizer and BioNTech began a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October 2020, and manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021 Pfizer Inc. (NYSE: PFE) and BioNTech SE (…